SALT LAKE CITY, May 19, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx", or the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it has entered into a securities purchase...
Hence then, the article about co diagnostics announces 3 0 million private placement priced at the market under nasdaq rules was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Co-Diagnostics Announces $3.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules )
Also on site :
- Im Rahmen von Gateway Gulf 2026: Beyon kündigt Erweiterung des Portfolios an grünen Rechenzentren auf drei Standorte an, da die Investitionen in Solarenergie zunehmen.
- ELEGOO startet seine Black-Friday- und Cyber-Monday-Angebote für 2026 mit bis zu 54 % Rabatt auf 3D-Drucker und Zubehör
- Hippocratic AI Unveils Polaris 6 Ultra, the First Healthcare Model With Bedside Intuition, Built on Real-Life Experience, With Lower Pricing